Reps will be saying that amlodipine (Norvasc) reduces the risk of cardiovascular events

Reps will be saying that amlodipine (Norvasc) reduces the risk of cardiovascular events.

This is for patients with coronary artery disease who are already on standard therapy with beta-blockers and statins.

A recent trial suggests amlodipine works at least as well as enalapril for add-on therapy.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote